Company / Operating Margin
Dianthus Therapeutics, Inc. /DE/ Operating Margin History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-8739.3%
FY2025
5-year range
-8739.3% / -1704.7%
FY2024-FY2025
Trend
-412.7%
vs FY2024
Sector context
#132 of 135
Health Care
What the data says
Among 135 Health Care companies, Dianthus Therapeutics, Inc. /DE/ is in the bottom 2% for operating margin.
Based on SEC 10-K filings.
-8739.3% in FY2025.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 135This company -8739.3% Sector average -774.4%
▼
-1028.5% below sector average
Key checks
Key Insights
- In FY2025, operating margin decreased 412.7% year-over-year.
- Currently 7964.9pp below the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.46 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -8739.3% | -412.7% |
| FY2024 | -1704.7% | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026